MedTrace Logo

Clinical Investigation of the Vision-R800 Device.

NCT04208750 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 119

Last updated 2022-03-14

Study results available
· View outcomes & findings →

Summary

Randomized, bilateral, cross-over dispensing study of a standard and VR800 refraction and associated spectacle lenses.

Conditions

Interventions

DEVICE

Vision R-800 Phoropter

Refraction utilizing the Vision R-800 Phoropter with resulting glasses

DEVICE

Standard Phoropter

Refraction utilizing the standard phoropter with resulting glasses

Sponsors & Collaborators

  • Pete Kollbaum, OD, PhD

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-11-18
Primary Completion
2021-02-01
Completion
2021-02-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04208750 on ClinicalTrials.gov